Table 3.
Predictors of 1-year mortality in non-small cell lung cancer patients by univariate analysis and multivariate logistic regression analysis.
| Variable | Comparison | Univariate ORb (95% CIc) |
P value | Multivariate ORb (95% CIc) |
P Value |
|---|---|---|---|---|---|
| Gender | Male versus female | 3.744 (1.671~8.391) | 0.001 | 4.676 (1.542~14.175) | 0.006 |
| Liver metastasis | Yes versus no | 6.000 (1.231~29.233) | 0.027 | ||
| Brain metastasis | Yes versus no | 2.667 (0.920~7.730) | 0.071 | 5.378 (1.012~28.582) | 0.048 |
| First-line treatment status | Disease control versus progression | 0.363 (0.162~0.811) | 0.013 | ||
| Performance status | 2 versus 0 & 1 | 9.935 (1.163~84.878) | 0.036 | ||
| Charlson comorbidity index | Per 1 unit decrease | 0.813 (0.674~0.981) | 0.031 | ||
| CD31+CD42b−AN-V− (counts/mL)a | Per 1 unit decrease | 0.9996 (0.999~1.000) | 0.021 | 0.9995 (0.999~1.000) | 0.007 |
aCD31+CD42b−AN-V− = endothelial-derived activated microparticle.
bOdds ratio.
cConfidence interval.